Evolent Health, Inc. EVH 深 滬
已收盤 12-19 16:00:00 美东时间
3.99
+0.020
+0.50%
華盛通- 最 高4.17
- 今 開3.96
- 成交量 378.50万股
- 最 低 3.925
- 昨 收 3.97
- 總市值 4.47亿
- 52周最高 12.9794
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 3.495
- 委 比 48.83%
- 總股本 1.12亿
- 歷史最高 39.779
- 量 比 1.04
- 振 幅 6.17%
- 歷史最低 3.495
- 每 手 1
- 風險率 2.07%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多BlackLine acquires WiseLayer to enhance its AI capabilities
BlackLine (BL) said on Monday that it has acquired WiseLayer, a New York-based company that has pioneered a digital workforce of AI-powered agents to automate finance and accounting processes. Terms ...
12-16 05:18
GXO stock falls as Brad Jacobs steps down as non-executive chair
GXO Logistics (GXO) on Monday said that Brad Jacobs will step down as non-executive chairman of the board, effective December 31, 2025, sending shares lower in early trading. Patrick Byrne will assume...
12-15 20:48
Activist Engaged Capital demands BlackLine's books, records
Activist Engaged Capital is demanding books and records from BlackLine (BL) related to the company's handling of multiple acquisition offers, including a $66/share offer from SAP (SAP). Engaged, whic...
11-25 02:33
美股大行评级 | 最高130美元！11家大行集体上调沃尔玛目标价；戴康工业、Gap、罗斯百货等均或多家大行上调目标价
今日重点评级关注：Canaccord Genuity：维持Fractyl Health"买入"评级，目标价从6美元升至8美元；HC Wainwright & Co.：维持MediWound"买入"评级，目标价从31美元升至36美元
11-24 11:23
Citigroup Maintains Buy on Evolent Health, Lowers Price Target to $9.5
Citigroup analyst Daniel Grosslight maintains Evolent Health (NYSE:EVH) with a Buy and lowers the price target from $11.5 to $9.5.
11-22 04:18
美股大行评级 | Stifel上调特斯拉目标价升至508美元；多家大行上调Vita Coco目标价最高至58美元
今日重点评级关注：HC Wainwright & Co.：维持Oncolytics Biotech"买入"评级，目标价从5美元升至10美元；HC Wainwright & Co.：维持Barinthus Biotherapeutics"买入"评级，目标价从3美元升至4美元
11-18 15:28
美股大行评级 | 花旗上调Bilibili目标价升至27美元； 摩根士丹利上调英伟达目标价升至220美元；Ardent Health、Stubhub遭多家大行下调评级
花旗上调Bilibili目标价升至27美元； 摩根士丹利上调英伟达目标价升至220美元；Ardent Health、Stubhub遭多家大行下调评级>>
11-17 10:49
Canaccord Genuity Maintains Buy on Evolent Health, Lowers Price Target to $9
Canaccord Genuity analyst Richard Close maintains Evolent Health (NYSE:EVH) with a Buy and lowers the price target from $16 to $9.
11-15 01:41
美股大行评级 | 思科、On Holding、派拓网络等获多家机构上调目标价；Circle 遭富国、德银等多家机构下调目标价
今日重点评级关注：HC Wainwright & Co.：维持PDS Biotechnology"买入"评级，目标价从13美元升至15美元；HC Wainwright & Co.：维持PepGen Inc."买入"评级，目标价从18美元升至20美元
11-14 10:43
美股大行评级 | 富国银行上调AMD目标价升至345美元；花旗上调礼来目标价升至1500美元；巴克莱上调腾讯音乐目标价升至28美元
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从12美元升至15美元；Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从106美元升至107美元
11-13 09:58
